Enantioselective Analysis of Crizotinib by Chiral LC Method
chromatographic separation was achieved on chiralcel OD-H (25 × 0.46 cm, 5 μ) column at a detector wavelength of 268 nm using an isocratic mobile phase comprising a mixture
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
chromatographic separation was achieved on chiralcel OD-H (25 × 0.46 cm, 5 μ) column at a detector wavelength of 268 nm using an isocratic mobile phase comprising a mixture
cardiac glycoside. A reversed-phase HPLC analysis was performed using C18-150 × 4.6 mm column with 10 ul injection volume and Methanol: Water as a mobile phase
topical dosage form. Enable HPLC ODS C18 G (250 × 4.6 mm, 5 μm) column was used along with mobile phase containing 20 mM ammonium acetate buffer (pH-4.8 adjusted with
pharmaceutical forms was developed and validated. A Phenomenex Gemini-NX C18 Column (250 mm length, 4.6 mm diameter, 5 μm particle size) with a mobile phase containing of Methanol: Sodium
range of 10-60 μg/ml. The chromatographic separation was achieved on Shodex C18 column with isocratic mode using a mixture of methanol: phosphate buffer (pH 7.2) in the ratio
been developed and validated. Analysis was operated on Symmetry® Acclaim™ RSLC 120 C18 column (100 mm, 2.1 mm, 2.2 μm) whose temperature was maintained at 60°C. Meanwhile mobile phase
HPLC) method. Chromatographic separations were carried using Inertsil ODS (4.6 × 250 mm, 5 μm) column with a mobile phase composition of 0.1% ortho phosphoric acid buffer and Acetonitrile
peak using Agilent Zorbax Eclipse XDB-C8, (100 mm × 4.6 mm, 3.5 μm) column with a run time is 2.5 min. Budesonide and levenorgestreol were recorded at the total
Hydrochlorothiazide (HCTZ) in their combined dosage forms. Separation was performed on Inertsil ODS-3 column (C18, 150 mm x 4.6 mm, 5 μm) using photodiode array (PDA) detection
therapeutically less-exploited and widely used only for culinary purpose, using analytical techniques viz. column chromatography, high performance thin layer chromatography (HPTLC.) and nuclear magnetic resonance…
chromatographic separation was achieved on Thermoscientific BDS Hypersil C18 (250 × 4.6 mm, 5μl) column using a mixture of methanol and 0.1% v/v triethylamine (pH 6) in the ratio
include isocratic mode on a C18 Qualisil BDS (250 mm × 4.5 mm × 5 mm) column using mobile phase containing potassium dihydrogen ortho phosphate buffer (pH 7.4) and methanol
method was validated by using Acquity UPLC HSS C18 (100 mm × 1.8 μ) column, the column temperature was maintained at 25°C and the run time 3 min. The mobile
Acquity UPLC BEHC18 (100 mm × 2.1 mm ID), 1.7ï particle size column is finalized for testing purpose with a detection wavelength of 260 nm. Typical retention times
estimation of cilnidipine in pharmaceutical dosage forms. separation was achieved on Symmetry C18 column (4.6 x 150mm), with mobile phase consisting of ortho phosphoric acid buffer pH 4 and Acetonitrile
Synthetic Mixture. The using Phenomenex Luna C18 (250 mm x 4.6 mm, 5 μm) column in Isocratic mode, with Mobile Phase containing Methanol: Water: ACN (pH 3.7 adjusted with
combined dosage form. The using Kromasil C-8 (250×4.6 mm, 5 μm) column in Isocratic mode, with Mobile Phase Acetonitrile : Phosphate buffer
Q2R1 guidelines. The RP-HPLC method was developed by the isocratic technique on a column of Kromasil C8 (250×4.6 mm, 5 μm). The retention time
Synthetic Mixture. The using Phenomenex Luna C18 (250 mm x 4.6 mm, 5 μm) column in Isocratic mode, with Mobile Phase containing ACN: Water: Methanol in the ratio
carried out on Acquity UPLC @BEH C18, (100 mm x 2.1 mm), 1.7 μm column using the gradient composition of mixture of phosphate buffer pH 6.8 and acetonitrile in ratio
samples was developed and validated. The chromatographic separation was accomplished on a C 18 column (Inertsil ODS 3V C-18, 250 × 4.6 mm, 5 μ )using a mixture of Buffer
form was developed successfully. Chromatographic separation was performed on Phenomenex Gemini C18 stainless steel column with dimension 250 × 4.6 mm, 5 μm particle size. The mobile phase consisting
determination, mixture of Potassium phosphate:acetonitrile(52:48) was used as mobile phase, the column having length of 4.6 mm × 25 cm and containing packing L7 which is maintained
High pressure liquid chromatography. The method was carried out on a Phenomenex kromosil C18 column (250 × 4.6 mm, 5μ) using mobile phase of 2ml orthophosphoric acid in 1000ml water
validated for the estimation of Dasatinib in pharmaceutical dosage forms. An Cosmicsil BDS C18 column (150 mm x 4.6 mm), 5 μ particle size was used as stationary phase with
For authors and organisers
Find the right journal for your paper and submit your manuscript.